Pfizer Reaffirms Full Year 2024 Guidance and Offers 2025 Earnings, Revenue Outlook
MT Newswires Live12-17
Pfizer (PFE) said Tuesday it continues to expect full year 2024 adjusted earnings in the range of $2.75 to $2.95 per diluted share on a revenue of $61.0 billion to $64.0 billion.
Analysts surveyed by FactSet expect non-GAAP earnings of $2.91 per share on a revenue of $62.89 billion.
The company expects full year 2025 adjusted earnings in the range of $2.80 to $3.00 per diluted share on revenues of $61.0 billion to $64.0 billion.
Analysts surveyed by FactSet expect non-GAAP earnings of $2.86 per share from a revenue of 63.22 billion.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
